These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 796526)

  • 61. The effect of aspirin dosing on platelet function in diabetic and nondiabetic patients: an analysis from the aspirin-induced platelet effect (ASPECT) study.
    DiChiara J; Bliden KP; Tantry US; Hamed MS; Antonino MJ; Suarez TA; Bailon O; Singla A; Gurbel PA
    Diabetes; 2007 Dec; 56(12):3014-9. PubMed ID: 17848625
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [The thromboxane-synthesis inhibitor Ibustrin in the treatment of diabetic angiopathies].
    Shestakova MV; Vykhristiuk SG; Milen'kaia TM; Tokmakova AIu; Dedov II
    Ter Arkh; 1996; 68(10):18-22. PubMed ID: 9026936
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Progression of occlusive atherosclerosis. Long-term administration of pyridinol carbamate.
    Redisch W; Clauss RH; Rouen LR; Katz MC; Terry EN
    Arch Surg; 1975 Mar; 110(3):258-61. PubMed ID: 803830
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Clinical evaluation of pyridinolcarbamate effect on patients with obliterating atherosclerosis (author's transl)].
    Roztocil K; Oliva I; Linhart J; Prerovský I; Modr Z
    Cas Lek Cesk; 1976 Aug; 115(33-34):1051-5. PubMed ID: 975177
    [No Abstract]   [Full Text] [Related]  

  • 65. The effect of Prodectin (pyridinolcarbamate) treatment of the circulation rate in obliterating arterial diseases of the lower extremities.
    Fényes G; Gótzy G; Fehrentheil L
    Ther Hung; 1975; 23(2):64-66. PubMed ID: 1188705
    [No Abstract]   [Full Text] [Related]  

  • 66. Systemic effects of ADP-induced platelet aggregation and their modification by aspirin and by pyridinolcarbamate.
    Kobayashi I; Didisheim P
    Thromb Diath Haemorrh; 1973 Sep; 30(1):178-90. PubMed ID: 4788746
    [No Abstract]   [Full Text] [Related]  

  • 67. [Effects of Tebonin (extract from leaves of ginkgo biloba L.) in the treatment of senile peripheral arteriopathies].
    Locatelli GR; Sorbini E
    Minerva Cardioangiol; 1969 Dec; 17(12):1103-8. PubMed ID: 5373482
    [No Abstract]   [Full Text] [Related]  

  • 68. [Treatment of thrombosis as a result of stress (the Paget-Schroetter syndrome) in diabetes with fibrinolysin and anticoagulants].
    Ospanov TO; Bekishev BB
    Vestn Khir Im I I Grek; 1973 Mar; 110(3):115-6. PubMed ID: 4268300
    [No Abstract]   [Full Text] [Related]  

  • 69. [The importance of pyridinolcarbamate and clofibrate association in the treatment of arteriosclerosis].
    Pola P
    Minerva Cardioangiol; 1975 Apr; 23(4):261-9. PubMed ID: 1095958
    [No Abstract]   [Full Text] [Related]  

  • 70. [The importance of pyridinolcarbamate and clofibrate association in the treatment of arteriosclerosis].
    Pola P
    J Pharm Sci; 1975 Jan; 64(1):261-9. PubMed ID: 1094102
    [No Abstract]   [Full Text] [Related]  

  • 71. Early detection of vascular disease.
    Leonberg SC; Elliott FA
    Am Fam Physician; 1974 Feb; 9(2):150-2. PubMed ID: 4810871
    [No Abstract]   [Full Text] [Related]  

  • 72. [Combined treatment of diabetic retinopathy and angiopathy with stilbestrol and testosterone].
    Szpilewski S; Lodygowska K
    Klin Oczna; 1974 Sep; 44(9):895-9. PubMed ID: 4408963
    [No Abstract]   [Full Text] [Related]  

  • 73. The role of angiotensin II type 1 receptor blockers in the prevention and management of diabetes mellitus.
    Mathur G; Noronha B; Rodrigues E; Davis G
    Diabetes Obes Metab; 2007 Sep; 9(5):617-29. PubMed ID: 17697055
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Erythrocyte and thrombocyte aggregation disorders in the pathogenesis of diabetic retinopathy and the potentials of disaggregation therapy].
    Tartakovskaia AI; Arkhangel'skaia EN; Dudnikova LK
    Vestn Oftalmol; 1983; (6):59-62. PubMed ID: 6659243
    [No Abstract]   [Full Text] [Related]  

  • 75. [Experimental study of the anti-inflammatory action of pyridinolcarbamate].
    Shvarts GIa; Liberman SS; Mashkovskiĭ MD; Berliand EA
    Farmakol Toksikol; 1975; 38(4):434-6. PubMed ID: 1213130
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The effect of vasodilating drugs in peripheral vascular disease.
    Karpman HL; Okun R
    Geriatrics; 1972 Nov; 27(11):101-7. PubMed ID: 4562846
    [No Abstract]   [Full Text] [Related]  

  • 77. COMPLICATIONS OF DIABETES MELLITUS (STUDY OF 2012 CASES).
    ABOU-KHATWA H; GIRGIS B; BEDBAWI E
    J Egypt Med Assoc; 1963; 46():177-87. PubMed ID: 14058972
    [No Abstract]   [Full Text] [Related]  

  • 78. [Proliferating diabetic retinopathy and diabetic nephropathy].
    Fischer F
    Wien Med Wochenschr; 1969 Apr; 119(15):285-7. PubMed ID: 5769604
    [No Abstract]   [Full Text] [Related]  

  • 79. [Use of prodektin in the treatment of children with vasomotor rhinitis].
    Iaroslavtsev VA; Iaroslavtsev AK
    Vestn Otorinolaringol; 1987; (3):79. PubMed ID: 3617346
    [No Abstract]   [Full Text] [Related]  

  • 80. [Use of prodectin in pulmonary tuberculosis].
    Safarov RN; Makinskiĭ AI
    Vrach Delo; 1981 Nov; (11):83-4. PubMed ID: 7342450
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.